Article information

DOI

https://doi.org/10.1039/D1RA90038B

Article type

Retraction

Submitted

18 Jan 2021

Accepted

18 Jan 2021

First published

26 Jan 2021

This article is Open Access

Permissions

Request permissions

Retraction: Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/AKT signaling pathway

L. Fisher, RSC Adv., 2021, 11, 5022 DOI: 10.1039/D1RA90038B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Tweet

Share